30Jun
Healthcare M&A prospers, despite fall in deal activity
The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmaceuticals has proven resilient through the COVID-19 crisis - Although pharma, medical and biotech (PMB) M&A deal value for Q1 2020 came in at US$39.3 billion, 78% below the year before, this was primarily due to the outsized US$87.8 billion deal between Bristol-Myers Squibb and Celgene in early 2019....
By:
White & Case LLP
Related
Officer Was Subjected to Sexual Harassment, Retaliation and Finally Constructive Discharge, Federal ...
Read More >
During the final months of 2019, the Mine Safety and Health Administration (“MSHA”) advised the mi...
Read More >
As companies increasingly look to artificial intelligence (“AI”) solutions to streamline their bus...
Read More >
In Sunday’s Oscars acceptance speech for the animated short film “Hair Love,” in which an African...
Read More >
CareerSource Florida, a government agency serving the state of Florida, recently released a report h...
Read More >
Assembly Bill 5, a proposed new law currently pending in the California legislature, would limit and...
Read More >